National Institutes of Health
Publishes on Glycosylation and Glycoproteins Research, Monoclonal and Polyclonal Antibodies Research, Enzyme function and inhibition. 39 papers and 4.6k citations.
Add your photo, update your bio, and get notified when your ranking changes.
ADVERTISEMENT RETURN TO ISSUEPREVArticleNEXTMouse myeloma proteins with antihapten antibody activity. Protein produced by plasma cell tumor MOPC-315Herman N. Eisen, Ernest S. Simms, and Michael. PotterCite this: Biochemistry 1968, 7, 11, 4126–4134Publication Date (Print):November 1, 1968Publication History Published online1 May 2002Published inissue 1 November 1968https://pubs.acs.org/doi/10.1021/bi00851a048https://doi.org/10.1021/bi00851a048research-articleACS PublicationsRequest reuse permissionsArticle Views195Altmetric-Citations220LEARN ABOUT THESE METRICSArticle Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.Citations are the number of other articles citing this article, calculated by Crossref and updated daily. Find more information about Crossref citation counts.The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on the Altmetric Attention Score and how the score is calculated. Share Add toView InAdd Full Text with ReferenceAdd Description ExportRISCitationCitation and abstractCitation and referencesMore Options Share onFacebookTwitterWechatLinked InRedditEmail Other access optionsGet e-Alertsclose Get e-Alerts
BALB/c mice immunized with myeloma proteins 315 or 460 made antibodies to the individually specific ("idiotypic") determinants of these proteins and suppressed growth of the corresponding transplanted tumor cells (MOPC-315 or MOPC-460). Stable, variant MOPC-315 tumors that produce only the light chain of protein 315 grew in several of the mice immunized with this protein, probably because the anti-idiotypic immune response selects against those myeloma cells that form the intact myeloma protein.